Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut
Year: 2014
G0536-01 Consent Conditions issued to The GUIDE Department, St. James's Hospital, Dublin on 22 July 2014 for a clinical trial using a Genetically Modified Organism (GMO)
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine MVA-NSmut
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine AdCh3NSmut1
Year: 2014
How to make a Representation to the EPA regarding Deliberate Release G0536-01
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine AdCh3NSmut1
Year: 2014
Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial
Year: 2013
All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.
Year: 2013
Inspector's Memo to Board for approval to modify condition
Year: 2013
Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition
Year: 2013
How to make a representation to the EPA about the proposed Deliberate Release G0493
Year: 2013
An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8
Representations received from members of the public in response to Intervet International BV's notification, June 2013
Year: 2013
The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine
Year: 2013
List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493
Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine
Year: 2013
An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.
Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
